Navigation Links
CSA Medical Selected to Present at Mid-Atlantic Bio Conference
Date:10/28/2010

BALTIMORE, Oct. 28 /PRNewswire/ -- CSA Medical, Inc. (www.CSAmedical.com) has been selected to present the company's technology and business plans for its proprietary spray cryotherapy platform at the Mid-Atlantic Bio Conference. CSA Medical will be one of only eleven companies presenting in the emerging growth category. Twenty five companies in total will present across three categories. More than 800 national and international industry leaders, government representatives, executives, researchers, investors, entrepreneurs, and professional services firms will gather at the Mid-Atlantic Bio conference at the North Bethesda Marriott Convention Center in Bethesda, MD. CSA Medical will present on Thursday, October 28th at 2:20 pm when company executives, Ric Hughen and Steve Schaefer, will be on hand to present financial highlights, new product development and ongoing commercialization plans for CSA Medical's novel Spray Cryotherapy technology.

CSA Medical is first to harness the power of extreme cold, liquid nitrogen (-196 C), therapeutic energy delivery inside the body. This unique technology (device, catheter and agent) allows delivery of therapeutic doses of a cryogen to flash freeze and destroy diseased tissue inside the body.

"We are thrilled to be selected as this conference is hosted by some of the region's most influential bioscience and investor associations, including the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO)," said Steve Schaefer, the company's President and CFO. "This is quite an honor and reflects strong progress that the company has made gaining customers, treating over 6,000 patients and freezing disease."

The Mid-Atlantic Bio Conference, scheduled October 27-29, 2010, in Bethesda, Maryland, is co-hosted by the Tech Council of Maryland/MdBio (TCM/MdBio), the Mid-Atlantic Venture Association (MAVA), and the Virginia Biotechnology Association (VaBIO). Mid-Atlantic Bio benefits from broad regional support from the investor and greater business communities, academic institutions, government agencies, and partnering regional associations. For more information, or to register or sponsor, please visit www.midatlanticbio.org.

CSA Medical, Inc. develops and manufactures a proprietary therapeutic interventional platform, the CryoSpray Ablation™ System. The CSA System utilizes a patented spray cryogenic technology that allows a physician to freeze and destroy a wide range of unwanted tissues via an endoscope. Please visit www.CSAmedical.com for more information.


'/>"/>
SOURCE CSA Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ZONARE Medical Systems Ranked Among Fastest Growing Companies By Silicon Valley Business Journal
2. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
3. OICR Makes Equity Investment in Medical Information Company
4. Reportlinker Adds Biobanking for Medical R&D: Technology and Market 2010-2025
5. Philadelphia Eagles Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line
6. Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement
7. Elsevier Congratulates its British Medical Association (BMA) Award Winning Medical Authors and Editors
8. 2010 Lasker Awards Honor Trailblazers in Medical Research and Clinical Care
9. IntriMed Technologies Launched to Address Challenges Faced by Medical Device Manufacturers
10. DSM Biomedical Announces Continued Partnership with Spinelab
11. NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , February 5, 2016 Amarantus ... biotechnology company focused on developing products for Regenerative Medicine, ... Rare Pediatric Disease Designation (RPDD) from the US Food ... with MANF. MANF was previously granted orphan drug designation ... --> Amarantus BioScience Holdings, Inc. (OTCQB: ...
(Date:2/4/2016)... Francisco, CA (PRWEB) , ... February 04, 2016 ... ... of enterprise talent development and compliance training, today announced an interactive FDA ... Morf Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course on ...
(Date:2/4/2016)... 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... Edward Lanphier , Sangamo,s president and chief executive ... Sangamo,s ZFP Therapeutic ® development programs and an ... ET on Thursday, February 11, 2016, at the Leerink ... conference is being held in New York ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... Forensics Club, takes place February 5-6 at the University’s student center, Kehr ... activities such as workshops and competitions for ample networking, learning and collaborating ...
Breaking Biology Technology:
(Date:2/3/2016)... , Feb. 3, 2016 ... addition of the "Emotion Detection and ... Learning, and Others), Software Tools (Facial Expression, ... End Users,and Regions - Global forecast to ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 Technology ... service presents an analysis of the digital and computed ... Malaysia , and Indonesia ... current trends and market size, as well as regional ... by country and discusses market penetration and market attractiveness, ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
Breaking Biology News(10 mins):